RELMADA THERAPEUTICS, INC. (RLMD)
Relmada Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in addressing diseases of the central nervous system. It develops esmethadone, an N-methyl-D-aspartate receptor antagonist for the treatment of CNS diseases, and oral agent for depression and other potential indications. The company was founded by Paolo Manfredi on May 31, 2012 and is headquartered in Coral Gables, FL.
Address
2222 PONCE DE LEON BLVD. 3RD FLOOR
CORAL GABLES, FL 33134
Founded
2012
Number of Employees
20
Website
http://www.relmada.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)